TFC Financial Management, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1827844
BOSTON, MA
Position in REGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$55,495
-$24,859 QoQ
Shares Held
89
-14.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,117
of 1,322 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TFC Financial Management, Inc. holds $462,229 across 45 Biotechnology names. REGN ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
316 | $156,966 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
89 | $55,495 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
1,650 | $51,579 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
620 | $33,814 | |
| 5 | REPL |
Replimune Group, Inc.
|
2,691 | $29,789 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
72 | $21,674 | |
| 7 | MRNA |
Moderna, Inc.
|
264 | $18,487 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
211 | $16,514 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,495 | 89 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $80,354 | 104 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $80,274 | 104 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $57,913 | 103 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $53,550 | 102 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $128,114 | 202 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $193,753 | 272 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $277,527 | 264 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $277,471 | 264 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $253,134 | 263 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $230,990 | 263 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $216,438 | 263 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $188,976 | 263 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $215,277 | 262 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $188,308 | 261 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $179,795 | 261 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $59,704 | 101 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $69,842 | 100 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $63,152 | 100 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $605 | 1 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $558 | 1 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $473 | 1 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $483 | 1 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $559 | 1 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||